Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

ALGSALGS
Showing 8 of 23 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ALIGOS THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 83,055 shares of ALGS (ALIGOS THERAPEUTICS INC), worth $479,227 as of 2026-Q2. ALGS represents 0.0% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$479,227

Current Shares

83,055

Total Value Change

-$240,029

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
83,055
0.0%
$479,2270.0%$5.77
0
2026-Q1
Unchanged
83,055
0.0%
$617,0990.0%$6.85
0
2025-Q4
Unchanged
83,055
0.0%
$774,0730.0%$9.12
0
2025-Q3
Unchanged
83,055
0.0%
$813,9390.0%$9.62
0
2025-Q2
Unchanged
83,055
0.0%
$598,8270.0%$7.21
0
2025-Q1
Unchanged
83,055
0.0%
$685,2040.0%$9.12
0
2024-Q4
Unchanged
83,055
0.0%
$3.3M0.0%$40.47
0
2024-Q3
Decreased
83,055
-96.0%
$719,2560.0%$8.04
0

Other major holders of ALGS: HHLR ADVISORS, LTD., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used